Parallel Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60 | Hold |
250
| – | – | ﹤0.01% | 3455 |
|
|
2025
Q1 | $49 | Hold |
250
| – | – | ﹤0.01% | 3453 |
|
|
2024
Q4 | $135 | Sell |
250
-6,933
| -97% | -$3.74K | ﹤0.01% | 3395 |
|
|
2024
Q3 | $6.83K | Buy |
7,183
+6,933
| +2,773% | +$6.59K | ﹤0.01% | 2506 |
|
|
2024
Q2 | $244 | Buy |
+250
| New | +$244 | ﹤0.01% | 3166 |
|
|
2022
Q2 | – | Sell |
-1,853
| Closed | -$4K | – | 2927 |
|
|
2022
Q1 | $4K | Buy |
1,853
+1,041
| +128% | +$2.25K | ﹤0.01% | 2328 |
|
|
2021
Q4 | $3K | Hold |
812
| – | – | ﹤0.01% | 2529 |
|
|
2021
Q3 | $4K | Buy |
812
+97
| +14% | +$478 | ﹤0.01% | 2401 |
|
|
2021
Q2 | $3K | Hold |
715
| – | – | ﹤0.01% | 2398 |
|
|
2021
Q1 | $4K | Sell |
715
-190
| -21% | -$1.06K | ﹤0.01% | 2215 |
|
|
2020
Q4 | $5K | Buy |
905
+190
| +27% | +$1.05K | ﹤0.01% | 1988 |
|
|
2020
Q3 | $6K | Hold |
715
| – | – | ﹤0.01% | 1905 |
|
|
2020
Q2 | $7K | Sell |
715
-372
| -34% | -$3.64K | ﹤0.01% | 1821 |
|
|
2020
Q1 | $2K | Buy |
+1,087
| New | +$2K | ﹤0.01% | 2086 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2394 |
|
|
2019
Q3 | – | Sell |
-314
| Closed | -$1K | – | 2375 |
|
|
2019
Q2 | $1K | Hold |
314
| – | – | ﹤0.01% | 2147 |
|
|
2019
Q1 | $1K | Hold |
314
| – | – | ﹤0.01% | 2140 |
|
|
2018
Q4 | $1K | Buy |
+314
| New | +$1K | ﹤0.01% | 1963 |
|